4 completed, 1 not yet recruiting. 3 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 3 | 2 | Completed 1, Not yet recruiting 1 |
Follow cefepime-zidebactam: new trials by email Literature Review of cefepime-zidebactam trials Research Report on cefepime-zidebactam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia Cefepime-Zidebactam, Ceftazidime-avibactam with or without Colistin - Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP) | Phase 3 | Not yet recruiting | Wockhardt | 324 | 2026-10-28 | 2026-10-21 |
| A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination. Zidebactam-Cefepime, Metronidazole, FEP-ZID - PHA1A | Phase 1 | Completed | Wockhardt | 30 | 2025-01-21 | 2025-09-16 |
| Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) Cefepime-zidebactam (FEP-ZID), Meropenem - Complicated Urinary Tract Infection, Acute Pyelonephritis | Phase 3 | Completed | Wockhardt | 530 | 2022-08-28 | 2026-05-22 |
| Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers WCK 5222, IV placebo matched to WCK 5222 / Moxifloxacin IV solution, Moxifloxacin 400-mg - QT/QTc Interval in Healthy Volunteers | Phase 1 | Completed | Wockhardt | 60 | 2017-02-09 | 2018-06-13 |
| To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal Impairment WCK 5222 - Renal Impairment | Phase 1 | Completed | Wockhardt | 48 | 2016-10-25 | 2018-08-02 |
Wockhardt (5)
United States (4) · Bulgaria (2) · India (2) · Lithuania (2) · Poland (2) · Bosnia and Herzegovina (1) · China (1) · Croatia (1) · Estonia (1) · France (1) · Georgia (1) · Greece (1) · Italy (1) · Mexico (1) · Moldova (1)